Y RNA derived small RNAs in Sjögren's syndrome : Candidate biomarkers?
© 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd..
Anti-Ro and anti-La antibodies are important in pathogenesis and diagnosis of Sjögren's syndrome (SS). Ro60, Ro52 and La are RNA binding proteins of Y RNA, which were discovered more than three decades ago. Significance of Y RNA is not appreciated as much as Ro and La in SS. It can be hypothesised that 5'-YsRNA, short fragment derived from Y RNA may be recognized by TLR7 in pDC, which induces type I interferon signature in SS. New genomics tools, namely RNA seq, enables assay of 5'-YsRNA in blood. 5'-YsRNA has the potential to be a novel biomarker of SS.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
International journal of rheumatic diseases - 20(2017), 11 vom: 01. Nov., Seite 1763-1766 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kabeerdoss, Jayakanthan [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 06.08.2018 Date Revised 13.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/1756-185X.13229 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM278191037 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM278191037 | ||
003 | DE-627 | ||
005 | 20231227125710.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/1756-185X.13229 |2 doi | |
028 | 5 | 2 | |a pubmed24n1223.xml |
035 | |a (DE-627)NLM278191037 | ||
035 | |a (NLM)29152879 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kabeerdoss, Jayakanthan |e verfasserin |4 aut | |
245 | 1 | 2 | |a Y RNA derived small RNAs in Sjögren's syndrome |b Candidate biomarkers? |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.08.2018 | ||
500 | |a Date Revised 13.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd. | ||
520 | |a Anti-Ro and anti-La antibodies are important in pathogenesis and diagnosis of Sjögren's syndrome (SS). Ro60, Ro52 and La are RNA binding proteins of Y RNA, which were discovered more than three decades ago. Significance of Y RNA is not appreciated as much as Ro and La in SS. It can be hypothesised that 5'-YsRNA, short fragment derived from Y RNA may be recognized by TLR7 in pDC, which induces type I interferon signature in SS. New genomics tools, namely RNA seq, enables assay of 5'-YsRNA in blood. 5'-YsRNA has the potential to be a novel biomarker of SS | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Sjögren's syndrome | |
650 | 4 | |a TLR7 | |
650 | 4 | |a Y RNA | |
650 | 4 | |a YsRNA | |
650 | 4 | |a type I interferon | |
650 | 7 | |a Antibodies, Antinuclear |2 NLM | |
650 | 7 | |a Autoantigens |2 NLM | |
650 | 7 | |a Genetic Markers |2 NLM | |
650 | 7 | |a RNA, Small Cytoplasmic |2 NLM | |
650 | 7 | |a Ribonucleoproteins |2 NLM | |
650 | 7 | |a SS-A antibodies |2 NLM | |
650 | 7 | |a SS-A antigen |2 NLM | |
650 | 7 | |a SS-B antibodies |2 NLM | |
700 | 1 | |a Sandhya, Pulukool |e verfasserin |4 aut | |
700 | 1 | |a Danda, Debashish |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of rheumatic diseases |d 2009 |g 20(2017), 11 vom: 01. Nov., Seite 1763-1766 |w (DE-627)NLM197180566 |x 1756-185X |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2017 |g number:11 |g day:01 |g month:11 |g pages:1763-1766 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/1756-185X.13229 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 20 |j 2017 |e 11 |b 01 |c 11 |h 1763-1766 |